VCM
PBYI icon

Versant Capital Management’s Puma Biotechnology PBYI Stock Holding History

Versant Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.85K Buy
+186
New +$1.64K ﹤0.01% 2621
2019
Q4 		– Sell
-63
Closed – – 1525
2019
Q3 		$0 Buy
+63
New +$680 ﹤0.01% 1534

Other funds holding PBYI

B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Versant Capital Management's PBYI Position: Q3 2026 in Review

Versant Capital Management opened a new position in Puma Biotechnology (PBYI) in Q3 2026: 186 shares worth $1.85K. The stake represents ﹤0.01% of the portfolio and ranks #2621 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in PBYI as recently as Q3 2019.

Versant Capital Management first reported a position in PBYI in Q3 2019 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Versant Capital Management held 186 shares of Puma Biotechnology worth $1.85K as of Q3 2026.
  • Puma Biotechnology was a new Versant Capital Management position in Q3 2026.
  • Puma Biotechnology made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2621 holding.
  • Versant Capital Management first reported a position in Puma Biotechnology in Q3 2019 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.